Medicament for improving eyesight

A technology of improving eyesight and improving weight, which is applied in the field of eye disease drugs, can solve the problems of not being able to take it at the same time, burdening more drug costs, and troubles for patients, and achieve the effects of improving physiological functions, high cure rate, and reducing troubles

Inactive Publication Date: 2011-06-15
朱宝民
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to solve the problem that some eye disease patients with blurred vision may have two or more symptoms at the same time. Such patients need to

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0007] Specific embodiment 1: This embodiment is a medicine for improving eyesight, consisting of Codonopsis 15-25g, Astragalus 15-25g, Poria 15-25g, Baizhu 10-20g, Angelica 10-20g, Rehmannia root 10-20g, and Red Peony ~20g, raw land 10~20g, branches 15~25g, medlar 15~25g, eucommia 10~20g, dodder 10~20g, raspberry 10~20g, salvia 10~20g, panax notoginseng 1~10g, dense flower 15 ~25g Baiwei 5-12g, 薢薢5-12g and chrysanthemum 15-25g are made. The method for preparing a medicine for eyesight of the present invention is to combine the Codonopsis, Astragalus, Poria, Atractylodes, Angelica, Rehmannia radix, Radix Paeoniae Rubra, Radix Rehmanniae, Branches, Wolfberry, Eucommia, Cuscuta, Raspberry, Salvia, Panax Notoginseng, Dense Menghua, Baiwei, 薆薢 and chrysanthemum grind are powders of 200 meshes, which can be mixed uniformly, sterilized and bagged, 5g per bag.

specific Embodiment approach 2

[0008] Specific embodiment 2: This embodiment is a medicine for improving eyesight, consisting of Codonopsis 16-24g, Astragalus 16-24g, Poria 16-24g, Atractylodes 11-19g, Angelica 11-19g, Rehmannia root 11-19g, and Red Peony ~19g, raw land 11~19g, branches 17~23g, wolfberry 16~22g, eucommia 12~18g, dodder 11~19g, raspberry 11~19g, salvia 12~18g, panax notoginseng 2~9g, dense Mongolia flower 16 ~23g Baiwei 6-11g, 薢薢6-11g and chrysanthemum 16-24g are made. Others are the same as the first embodiment.

specific Embodiment approach 3

[0009] Specific embodiment three: This embodiment is a medicine for improving eyesight, which is composed of Codonopsis pilosula 20g, Astragalus 20g, Poria 20g, Atractylodes 15g, Angelica 15g, Rehmannia root 15g, Red peony 15g, raw rehmannia 15g, branch 20g, wolfberry 20g, Eucommia 15g, dodder 15g, raspberry 15g, salvia 15g, panax notoginseng 5g, dense Mongolia flower 20g, Bai Wei 7g, 薢薢 8g and chrysanthemum 20g. Others are the same as the first embodiment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for improving eyesight. In the medicament, szechuan tangshen root, astragalus, large-headed atractylodes, Chinese angelica, rehmanniae vaporata, red paneoy root, rehmanniae praeparatum, gardenia fruit, medlar, eucommia bark, south dodder seed, raspberry, root of red-rooted salvia, notoginseng root, pale butterflybush flower, blackend swallowwort root, fish poison yarn and chrysanthemum are ground into 200-mesh powder, and are mixed uniformly, sterilized and packaged, wherein each bag contains 5 grams of medicament. The medicament is mainly used for treating patients who suffer from blurred vision caused by symptoms such as deficiency in kidney and yang, deficiency in blood and qi, diabetes mellitus, retinopathy, fundus hemorrhage, vitreous opacity, glaucoma or optic nerve pathological changes and the like, and 50 patients who suffer from the blurred vision are selected in the outpatient service of a hospital randomly to take the medicament. In the administration method and dosage, adults take twice every day, and takes 5 grams every time; for the children, the dosage is reduced by half; and 20 days is one treatment course, the total cure rate is 69 percent, the total cure rate of two treatment courses is 86.3, and the cure rate of three treatment course is 97.2 percent.

Description

Technical field [0001] The invention relates to a medicine for eye diseases, in particular to a medicine for eyesight. Background technique [0002] Some patients with unclear vision are caused by kidney deficiency, yang deficiency, blood deficiency and qi deficiency, diabetes, fundus disease, fundus hemorrhage, vitreous opacity, glaucoma or optic neuropathy. Some patients may have one of the above symptoms Some patients may have two or more symptoms at the same time. For example, fundus bleeding accompanied by vitreous opacity and diabetes, such patients need to prescribe several drugs at the same time, not only the cost of drugs, but also some drugs can not be taken at the same time, there must be a certain interval of time, causing a lot of trouble to the patient. Summary of the invention [0003] The purpose of the present invention is to solve that some patients with unclear vision may have two or more symptoms at the same time. Such patients need to prescribe several drugs ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8945A61P27/10
Inventor 朱宝民
Owner 朱宝民
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products